
Journal of Medicinal Chemistry p. 1613 - 1618 (1993)
Update date:2022-08-03
Topics:
Ohshima
Sato
Obase
Miki
Ishii
Kawakage
Shirakura
Karasawa
Kubo
A new series of 6,11-dihydrodibenz[b,e]oxepin derivatives exerting both thromboxane synthase inhibitory (TXS-I) and thromboxane receptor antagonist (TXRA) activities is described. (-)-11-[(3-Pyridylmethyl)thio]-6,11- dihydrodibenz[b,e]oxepin-2-carboxylic
View MoreAnhui Eapearl Chemical Co., Ltd.
Contact:86-562-5858458
Address:358 South Huaihe Road
Suzhou Chiral Pharmaceuticals Co., Ltd.
Contact:86-0512-63197058
Address:Building A, No. 2358, Chang'an Road, Wujiang Science Park
Shaanxi HuaTai Bio-fine chemical company Ltd
Contact:86-029-87862197
Address:No. 5, 3rd Floor, 29 Yanta North Road, Beilin Dist.
Nanjing Chemzam Pharmtech Co., Ltd.
Contact:+86-25-86462165,+86-13915979898
Address:C5-1,6 Maiyue Road,Maigaoqiao,Nanjing,Jiangsu,China
Beijing Tianjia Chemical Science & Technology Co.,Ltd
Contact:86-0550-2392698
Address:No.388, Shiliang Road (East),
Doi:10.1021/om00029a032
(1993)Doi:10.1039/jr9470000433
()Doi:10.1002/recl.19931120211
(1993)Doi:10.1039/J19700002922
()Doi:10.1021/ja00063a009
(1993)Doi:10.1039/c9cc08009k
(2020)